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Ocular Hypertension in Blacks
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Abstract
Ocular hypertension occurs when intraocular pressure (IOP) is greater than the 
normal range with no evidence of vision loss or damage to the optic nerve. Individuals 
with ocular hypertension have an increased risk for glaucoma. The mean normal 
IOP is 15 mmHg and the mean IOP of untreated glaucoma is 18 mmHg. Elevated IOP 
commonly occurs in patients over the age of 50 and is often due to enlargement of the 
lens, narrowing of the angle, iridolenticular apposition, and pigment liberation that 
obstructs the trabecular meshwork. Cataract surgery and lensectomy can lower IOP 
and reduce the risk of glaucoma. The global wealth inequality of Blacks has created 
health inequities that have led to decreased access to surgical care contributing to 
higher rates of blindness from glaucoma. Greater education on the benefits of early 
cataract surgery and trabecular bypass for higher risk patients, as well as addressing 
wealth and health inequities, can help to bend the curve of blindness from glaucoma.
Keywords: ocular hypertension, glaucoma, Blacks, cataract surgery,  
trabecular bypass, African-American
1. Introduction
Ocular hypertension occurs when the pressure in the eye (intraocular pressure or 
IOP) is beyond the normal value with no signs of vision loss or damage to the optic 
nerve. [1] With ocular hypertension, the aqueous humor (fluid produced by the 
eye) is poorly drained. The buildup of fluid in the eye leads to an increase in IOP that 
could potentially lead to damage of the optic nerve, causing glaucoma. [2] The mean 
normal IOP is 15 mmHg and the mean IOP of untreated glaucoma is 18 mm Hg. [1] 
Ocular hypertension typically presents with no signs or symptoms, making it dif-
ficult to detect without access to an eye exam. Individuals with elevated IOP may be 
treated with cataract surgery and lensectomy. [2, 3] To properly address populations 
at risk for ocular hypertension, it is advantageous to determine how demographic 
variables may impact an individual’s susceptibility to blindness. Demographic vari-
ables are innate or non-changeable determinants of a disease. Addressing inequities 
in wealth, health, and access to medical care, as well as improved education on the 
benefits of early surgical intervention, can bend the curve of blindness from glau-
coma. In this chapter, we use epidemiologic studies focusing specifically on Blacks to 
describe the prevalence and management of ocular hypertension.
2. Prevalence of ocular hypertension in blacks
In 2019, Black Americans made up 12.8% of US population, accounting for over 
42 million people. [4] Although Blacks make up a minority of the population, many 
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eye diseases, including ocular hypertension and glaucoma, affect a disproportion-
ate number of Blacks, leading to higher rates of vision loss than documented in 
white-Americans. [5] Definitions of race and ethnicity have been ill-defined in past 
medical literature, with many overlaps. Therefore, the term “Blacks” in this context 
refers to an individual of black African descent. The population of Blacks in the 
Caribbean is over 21 million and in Africa is close to one billion. [6] There are also 
issues of decreased access to surgery in both locations. [7]
While it has been universally accepted and documented that Blacks have higher 
prevalence of ocular hypertension, the degree of prevalence may differ for varying 
black populations. For example, the black-American and black-Caribbean popula-
tions studied in the Baltimore Eye Survey and the Barbados Eye Study, respectively, 
are ethnically unique. Both populations of Blacks presented with a high prevalence 
of ocular hypertension, but to a different degree. The prevalence of ocular hyper-
tension in the black-Caribbean population was reported at levels nearly twice that 
of the black-American population. [8–11] Studies have also reported a notably 
higher prevalence of ocular hypertension in Blacks in comparison to other racial 
groups (primarily white). [12, 13]
In response to a lack of substantial ocular research with Black study participants, 
extensive population-based studies including the Baltimore Eye Survey [9], The 
Ocular Hypertension Treatment Study [2], The Barbados Eye Study [8], and the 
African American Eye Disease Study [13] were created to address the dispropor-
tionate prevalence of eye diseases present in Blacks. Further studies are needed to 
continue to build upon this body of research, particularly to look at earlier interven-
tions of cataract surgery and trabecular bypass as an earlier intervention to prevent 
glaucoma.
3. Mechanism of ocular hypertension in blacks
Studies have shown that with age the crystalline lens increases in width. During 
accommodation, the iris bows posteriorly. With age there is increased contact 
between the posterior iris pigment epithelium and lens zonules leading to pigment 
liberation and obstruction of the trabecular meshwork. [14] This is often seen with 
heavier pigment in the trabecular meshwork inferiorly compared to superiorly on 
gonioscopy. [15] The increased width of the lens can also lead to pupillary block and 
iris obstruction of the trabecular meshwork leading to elevated intraocular pres-
sure. This common mechanism of ocular hypertension in persons over the age of 
50 is often overlooked by physicians. Current physicians and those in training must 
be better educated to look for this clinically and intervene promptly. Early cataract 
surgery and lensectomy is beneficial to remove the large lens and trabecular bypass 
to restore aqueous outflow via the obstructed trabecular meshwork. [14]
4. Genetic influence on ocular hypertension
Previous studies have shown intraocular pressure (IOP) to be highly heritable, 
indicating possible genetic influence on the development of ocular hypertension. 
[12, 16] There is additional substantial evidence suggesting that ocular hyperten-
sion leading to glaucoma may have a genetic component [17], but the specific 
genetic risk factors have not yet been identified. A 2012 genome wide association 
study conducted in 11,972 participants from The Netherlands, UK, Australia, and 
Canada investigated candidate genes in human ocular tissue to identify susceptibil-
ity to elevated IOP and glaucoma. [12] Elevated IOP commonly occurs in patients 
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over the age of 50 and often presents with enlargement of the lens, narrowing of the 
angle, iridolenticular apposition, or pigment liberation that obstructs the trabecular 
meshwork. Genes regulating these ocular components were studied and the results 
revealed that genetic variants expressed in genes GAS7 and TMCO1 were associ-
ated with changes in IOP in the populations studied. Both revealed only marginal 
evidence for ocular hypertension, as GAS7 was associated with a 0.19 mmHg 
decrease in IOP and TMCO1 was associated with a 0.28 mmHg increase in IOP. [12] 
Additional findings revealed that individuals of European ancestry expressed the 
GAS7 variant at 0.44 frequency while those of African ancestry expressed the same 
variant at 0.12 frequency. [12] The lower frequency of this variant in Blacks may 
reflect the elevated IOP common in individuals of African descent and requires 
further research.
While impressive strives have been made over the past two decades to identify 
genetic components of ocular diseases [18], a comprehensive understanding of 
the pathophysiology has frequently been limited to individuals of European and 
Asian ancestry, requiring an increased need for genetic research in Blacks and other 
understudied populations. For example, multiple genetic variants in genes associ-
ated with elevated IOP were discovered in non-Black populations and a majority 
do not replicate, nor have an effect, in Blacks. [19–21] In response to an increased 
need for the identification of genetic risk factors that underlie elevated IOP in the 
understudied population of Blacks, the Primary Open-Angle African American 
Glaucoma Genetics (POAAGG) study was created in 2014 and took place over the 
course of five years to address these research disparities. [22] This study identified 
a genetic variation known as a single nucleotide polymorphism (SNP) involved in 
the homeostasis of the trabecular meshwork. [23] The trabecular meshwork (TM) 
is located in the anterior portion of the eye and regulates the outflow of the aqueous 
humor into circulation. [24] If resistance increases in the TM during aqueous humor 
outflow, intraocular pressure may rise leading to ocular hypertension. By identify-
ing a genetic variant that may affect the TM in Blacks, the POAAGG study has made 
a pertinent finding to our understanding of the role of genetics in ocular hyperten-
sion and glaucoma. As one of the first large cohort studies with over 5,000 study 
participants, additional analyses are needed to further validate the implications of 
this study.
In addition, the progression of elevated IOP in Blacks leading to ocular hyper-
tension is likely a combination of genetic, environmental, aging and socioeconomic 
factors, as well as others not mentioned. These demographic variables will continue 
to be explored throughout this chapter.
4.1 Central corneal thickness in ocular hypertension
Intraocular pressure is routinely measured in clinical practice to assess various 
conditions within the eye, including that of the optic nerve and visual field. [25] 
Goldmann applanation tonometry is the most common technique used to measure 
IOP, but its accuracy and use as a diagnostic tool may be impeded by the rigidity of 
the cornea. [25] A thicker cornea may cause an overestimate of IOP and a thin-
ner cornea may cause an underestimate of IOP. The consensus on the necessity to 
correct IOP based on central corneal thickness is not yet clear. While CCT is statisti-
cally significant as a predictor of glaucoma development [2], it does not present as 
an independent risk factor. [26]
The Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma 
Prevention Study (EGPS) recognized central corneal thickness as one of the most 
significant predictors for primary open-angle glaucoma. [2, 27] The mean central 
corneal thickness is about 560 μ m and the risk for developing ocular hypertension 
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has been reported to nearly double (hazard ratio of 1.82) for every 40 μm decrease. 
[28] Patients with thin corneas (<555 μm) [2] may present with an underestimated 
IOP reading, placing the individual at potential risk if actual IOP is elevated. The 
primary diagnostic criteria for ocular hypertension is IOP, so any factor that hinders 
this measurement may lead to an errant diagnosis. Patients with ocular hyperten-
sion typically present with thicker corneas, which may lead to an overestimation of 
IOP, while primary open angle glaucoma patients present with thinner corneas. [29] 
While the influence of elevated IOP on central corneal thickness has not yet been 
determined, individuals whose IOPs have been reduced pharmacologically by at 
least 20% demonstrated no change in corneal thickness. [30]
Differences in central corneal thickness were noted between black Americans 
and white Americans. In the OHTS, Blacks were found to have thinner central 
corneal thickness (555.7 μm), resulting in lower applanation readings and a miscal-
culated estimation of the true level of IOP. [30] The South African Eye Study [31] 
also measured differences in central corneal thickness and compared the findings 
to measurements of intraocular pressure in Blacks, mixed ethnicity peoples, and 
whites. The findings revealed that Blacks had the thinnest corneas and highest IOP, 
followed by mixed ethnicity then white individuals.
These results suggest the possible need for refining the risk factor definitions 
when measuring central corneal thickness and IOP in varying populations. While 
obtaining a central corneal thickness measurements for all patients may not be 
necessary, patients with ocular hypertension should continue to be monitored to 
measure accurate IOP and determine possible susceptibility to glaucoma.
4.2  Morphological changes in the retinal nerve fiber layer in ocular 
hypertension
Differing from glaucoma, ocular hypertension presents with a normal optic 
nerve and no signs of damage. Ocular hypertension is often a precursor to glaucoma 
as abnormally high pressures in the eye may lead to damage of the optic nerve caus-
ing vision loss or blindness. [1] Studies have indicated differences in the structure 
of the optic nerve between Blacks and whites. [32–33] The optic disc area was 12% 
larger in Blacks compared to Whites. [32] The larger optic nerve may cause a greater 
strain at similar pressure levels, but it is not clear if larger optic discs affect one’s 
susceptibility to ocular hypertension as there are incongruous reports. [10, 34] The 
impact of these differences has been postulated to affect the increased susceptibility 
of Blacks to ocular hypertension and glaucoma.
The retinal nerve fiber layer (RNFL) is primarily comprised of retinal ganglion 
cell axons that progressively diminish in glaucoma. As a result, the RNFL thins con-
siderably and may present as an early manifestation of glaucoma. [35] As a precur-
sor to glaucoma, RNFL was measured in patients with ocular hypertension and the 
results revealed a significant thinning of RNFL of about 15% in ocular hypertensive 
eyes as compared to normal eyes [36] Other studies have yet to demonstrate signifi-
cant differences RNFL between normal eyes and those with ocular hypertension, 
possibly due to the sensitivity of the instruments used to measure and the study 
population. [36, 37]
5. Inequities contributing to ocular hypertension in blacks
Vision loss is a pertinent public health challenge that requires the efforts of many 
to overcome. [38, 39] Addressing these disparities involves contending with the 
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pervasive economic and racial inequalities that have had a disproportionate impact 
on Blacks, particularly in healthcare utilization. These inequities are evident in a 
2020 study documenting the recency of eye examinations among black adults over 
the age of 55. [40] In this study, 13.4% of participants (n = 740) reported having no 
eye examination in the last five years and nearly 25% had not had an eye exam in the 
last year. [40] Concerningly, 20% of study participants with diabetes mellitus were 
not instructed by other healthcare providers to seek annual eye examinations.
5.1 Health and wealth inequities in blacks
Systemic and social inequities have resulted in poor health outcomes in Blacks. 
[41] When examining wealth in the United States, there is countless evidence 
of extensive racial disparities. In 2016, the net worth of the average white fam-
ily in the US was nearly ten times more than that of a Black family at $171,000 
and $17,150 respectively. [42] These extensive differences in wealth and income 
reflect the consequences of years of discrimination, segregation, and inequal-
ity that mark the history of the US from its inception. The wealth gap between 
Blacks and whites in the US demonstrates the differences in opportunity afforded 
to citizens. [42] Colonialism has contributed to similar wealth disparities in the 
Caribbean and Africa. Differing from the circumstances in developing countries, 
the eye health care system in the United States is highly capable of delivering the 
care necessary to treat patients. [41, 43] However, much improvement is needed 
in the means by which education is delivered to the public and effective screening 
may take place.
The history of medicine and health care in the United States is tainted by a 
myriad of forms of injustice and violence towards Blacks that includes segregation 
of medical facilities, unequal healthcare access, and disdainful medical experi-
mentation. [44–45] Today, these inequalities are especially evident in employment, 
housing, and wealth opportunities in medically underserved areas and populations 
(MUA/P). [46–48] MUA/P have been defined by the Health Resources and Services 
Administration as areas or populations having too few health care providers, high 
poverty or high elderly populations. [49] In addition, there are also social factors 
that have had strong implications on the health outcomes of Blacks, particularly 
poverty, food insecurity, and affordable housing. Low-socioeconomic status and 
race have been independently associated with increased vision loss placing poor 
Blacks at an increased risk. [47] These social factors that have often led to poor 
health outcomes in Blacks are rooted in racism and implicit biases that have to be 
recognized and changed at the personal, medical, and institutional level in order to 
lead to change. [50]
Many studies have reported the association between visual impairment and poor 
quality of life, as well as physical and mental illness. [51–53] Unilateral and bilateral 
vision loss and blindness can impact a person’s quality of life by affecting their 
ability to read, walk, commute, and carry out daily activities. [54] In addition to the 
disparities previously mentioned, blindness can exasperate the inequities faced by 
Blacks in the US. Early treatment of ocular hypertension by reducing elevated IOP 
by 20% can reduce the risk of developing glaucoma in half [2], thereby reducing the 
risk of blindness. Earlier cataract surgery, clear lensectomy, and trabecular bypass 
may reduce it even more. Implementing measures to address ocular hypertension 
in Blacks can help reduce the risk of blindness and address health inequities in 
the medical community. In addition, public policy is needed to develop models of 




5.2 Insurance and access to care
Access to health care can impact one’s health outcomes. The utilization of 
healthcare may be determined by whether people know care is needed, whether 
obtaining care is wanted, and whether care can be accessed. [55] Access is often 
used to describe the ease of obtaining care, including its availability, the accommo-
dations provided, and affordability. Health care in the United States often cannot be 
utilized without insurance, regardless of the presence of a healthcare provider that 
is geographically accessible. The public health challenge regarding ocular hyperten-
sion is that if the elevated IOP was detected earlier on, further exasperation of the 
condition could be slowed and potential diseases could be prevented. [56–57] With 
newer surgical approaches progression can be halted with earlier cataract surgery/
clear lensectomy and trabecular bypass.
Successful treatments for elevated IOP have included topical medications, 
surgery, or laser. [58] Reducing IOP significantly may lead to a delay in progres-
sion to optic nerve damage, visual field loss, or glaucoma. [59] Several studies 
have reported the impact of lack of medical care on health outcomes. [60–61] The 
Salisbury Eye Evaluation Study [62] was a population-based study that sought 
to investigate the causes of blindness and visual impairments of adults between 
the ages of 65 and 84. The study revealed higher levels of blindness and visual 
impairments in Blacks compared to whites, with 37% of the conditions classified as 
surgically treatable and 44% categorized as targets for low vision remediation. The 
study was not able to identify patients whose eye condition was amenable and chose 
not to undergo surgery for reasons including financial barriers, fear of the surgical 
procedure, or absence of functional loss. It is important to encourage all patients, 
particularly those with ocular hypertension, to seek continuous to monitor their 
condition.
The Affordable Care Act (ACA) was enacted in March 2010 with its primary 
goals being to make affordable health insurance available to more people and to 
generally lower the cost of health care. [63] Better health outcomes in Blacks have 
been linked to increases in health insurance coverage under the ACA. [64] While 
uninsured rates were reduced, Black Americans remained 1.5 times more likely to be 
uninsured than non-Hispanic white Americans. [65] Additionally, data gained from 
the National Health Interview Survey conducted between 2014–2016 revealed that 
access and utilization of eye care is lower among racial and ethnic minorities. [66]. 
Increased access to health care and affordable insurance may improve the health 
outcomes of vulnerable populations with ocular hypertension.
6. Patient education for ocular hypertension
Patient education is an interactive process in which learning may take place 
between the healthcare provider and the patient. Increased patient education of 
vision health may lead to an increasing trend of eye doctor visits. Previous studies 
have reported that those with more education are more likely to seek care from an 
eye care professional as opposed to those with less education [67]. As a result of 
ocular hypertension, many Black patients were reported to present to an ophthal-
mologist with more extensive damage to the optic nerve as compared to whites. [68] 
As a result, the disease progression in Blacks was more vulnerable to malignancy 
even after intervention is initiated. Safer earlier cataract surgery and trabecular 
bypass are important treatment options that should be offered earlier.
Educating patients on ocular hypertension involves sharing the risk factors asso-
ciated with the eye condition such as family history, age, medical conditions, and 
7
Ocular Hypertension in Blacks
DOI: http://dx.doi.org/10.5772/intechopen.96606
past eye injuries, as well prevention and treatment options. Due to the asymptom-
atic presentation of ocular hypertension with no signs of vision loss, it is possible 
that patients have not/will not seek treatment until further damage and vision loss 
occur. Prior recorded interactions between physicians and patients have found that 
providers were less likely to educate Black patients about glaucoma and were also 
less likely to educate patients of lower health literacy about glaucoma medications. 
[69] It is important for the patient’s eye health that ocular hypertension and its 
potential progression to glaucoma are described and apprehensible, particularly to 
those in populations most at risk. Through patient education of ocular hyperten-
sion, the patient may better understand their susceptibility to eye disease and can 
seek early treatment if necessary.
7.  Prevention and implementation of changes to address ocular 
hypertension in blacks
Given the information presented in this chapter, initiation of treatment for ocular 
hypertension may be started earlier in Blacks with the possibility of arresting or 
reducing elevated IOP. The aging population of adults aged 65 and older is continu-
ously increasing with expectation of this number to reach nearly 90 million in the 
US by 2050. [70] In addition, growing levels of obesity increasing the prevalence 
of diabetes make an increasing number of individuals at risk for vision loss in the 
future. As the risk factors for ocular hypertension increase, recognition of patient 
vulnerabilities and systemic level changes are needed to ensure that the needs of 
patients are properly and conveniently addressed.
8. Conclusion
This chapter has demonstrated the unique demographic and ocular charac-
teristics that have affected Blacks in the progression of ocular hypertension. The 
combination of race, socioeconomic status, and access to treatment may influ-
ence the diagnosis and health outcome of individuals with ocular hypertension. 
Acknowledging these factors and implementing changes to promote early diagnosis 
and treatment, as well as addressing health and wealth disparities in high-risk 
populations, can lead to lower rates of glaucoma and blindness. Physician advice 
through patient education, as well as affordability, continuity, and frequent access 
to care has demonstrated a strong association with increased eye care services. 
[71] Diagnosis and early intervention of elevated levels of intraocular pressure and 
ocular hypertension may reduce the risk of glaucoma, vision loss, and blindness in 
future patients.
Conflict of interest





1 New York Eye and Ear Infirmary, Icahn School of Medicine of Mount Sinai, 
New York, NY, USA
2 School of Medicine, New York Medical College, Valhalla, NY, USA
*Address all correspondence to: dlarochemd@aol.com
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
9
Ocular Hypertension in Blacks
DOI: http://dx.doi.org/10.5772/intechopen.96606
References
[1] Sommer, A. Glaucoma: Facts and 
fancies. Eye 1996;10 295-301.
[2] Kass M, Heuer D, Higginbotham EJ, 
et al. The Ocular Hypertension 
Treatment Study: a randomized 
trail determines that topical ocular 
hypotensive medication delays 
or prevents the onset of primary 
open angle glaucoma. Archives of 
Ophthalmology. 2002;120 701-713.
[3] The Advanced Glaucoma 
Intervention Study (AGIS): 7. The 
relationship between control of 
intraocular pressure and visual field 
deterioration. American journal of 
ophthalmology. 2000;130 429-440.
[4] United States Census Bureau. 





[5] National Eye Institute. Eye Health 
Among African Americans. [Internet] 





[6] The World Bank. Countries and 
Economies Data [Internet] 2020. 
Available from https://data.worldbank.
org/country [Accessed 2021-02-07]
[7] World Health Organization. Eye 






[8] Leske M, Connell A, Schachat A, 
Hyman L. The Barbados Eye Study. 
Prevalence of open angle glaucoma. 
Archives of Ophthalmology. 
1994;112(6):821-829. DOI: 10.1001/
archopht.1994.01090180121046
[9] Tielsch JM, Katz J, Singh K, et al. 
A population-based evaluation of 
glaucoma screening: the Baltimore 




[10] Wilson M, Gallardo M. Glaucoma 
Risk Factors: Ethnicity and Glaucoma. 
In: Schacknow P, Samples J, editors. 
The Glaucoma Book. 1st ed. New York: 
Springer; 2010. p. 101-107.
[11] Friedman D, Wilson M, Liebmanm J, 
et al. An evidence-based assessment 
of risk factors for the progression of 
ocular hypertension and glaucoma. 
American Journal of Ophthalmology. 
2004;138(3):19-31. DOI: 10.1016/j.
ajo.2004.04.058
[12] van Koolwijk LM, Ramdas WD, 
Ikram MK, et al. Common genetic 
determinants of intraocular pressure 
and primary open-angle glaucoma. 
PLoS Genetics. 2012;8(5):e1002611. 
DOI: 10.1371/journal.pgen.1002611
[13] McKean-Cowdin R, Fairbrother- 
Crisp A, Torres M, Lastra C, et al.The 
African American Eye Disease Study: 
Design and Methods. Ophthalmic 
Epidemiology. 2018;25(4):306-314. DOI: 
10.1080/09286586.2018.1454965
[14] Laroche D, Nkrumah G, Ng C. 
Real-world efficacy of the Hydrus 
microstent in Black and Afro-
Latinx patients with glaucoma: a 
retrospective study. Therapeutic 
Advances in Ophthalmology. 
2020;12:2515841420964311. DOI: 
10.1177/2515841420964311.
[15] Lahola-Chomiak AA, 
Walter MA. Molecular Genetics 
of Pigment Dispersion Syndrome 
Ocular Hypertension
10
and Pigmentary Glaucoma: New 
Insights into Mechanisms. Journal of 
Ophthalmology. 2018;2018:5926906. 
DOI: 10.1155/2018/5926906.
[16] Jiao X, Yang Z, Yang X, et al. 
Common variants on chromosome 
2 and risk of primary open-angle 
glaucoma in the Afro-Caribbean 
population of Barbados. Proceedings. 
2009;106(40):17105-10. DOI: 10.1073/
pnas.0907564106
[17] Chan C, Wiggs J, Sobrin L. The 
Genetic Influence on Corticosteroid-
Induced Ocular Hypertension: A Field 
Positioned for Discovery. American 
Journal of Ophthalmology. 2019;202:1-5. 
DOI: 10.1016/j.ajo.2019.02.001
[18] Choquet H, Paylakhi S, 
Kneeland S, et al. A multiethnic genome-
wide association study of primary open-
angle glaucoma identifies novel risk loci. 
Nature Communications 2018;9:2278. 
DOI: 10.1038/s41467-018-04555-4
[19] Burdon KP, Macgregor S,  
Hewitt AW, et al. Genome-wide 
association study identifies 
susceptibility loci for open angle 
glaucoma at TMCO1 and CDKN2B-AS1. 
Nature Genetics. 2011;43(6):574-8. DOI: 
10.1038/ng.824.
[20] Vithana EN, Khor CC, Qiao C, et 
al. Genome-wide association analyses 
identify three new susceptibility loci for 
primary angle closure glaucoma. Nature 
Genetics. 2012t;44(10):1142-1146. DOI: 
10.1038/ng.2390.
[21] Masakazu N, Yoko I, Takazumi T, 
et al. Three susceptible loci associated 
with primary open-angle glaucoma 
identified by genome-wide association 
study in a Japanese population. 
2009;106(31):12838-12842. DOI: 
10.1073/pnas.0906397106
[22] Khachatryan N, Pistilli M, 
Maguire MG, et al. Primary Open-Angle 
African American Glaucoma Genetics 
(POAAGG) Study: gender and risk of 
POAG in African Americans. PLoS One. 
2019;14(8):e0218804. DOI: 10.1371/
journal.pone.0218804.
[23] Gudiseva H, Verma S, Chavali V, 
et al. Genome wide-association study 
identifies novel loci in the Primary 
Open-Angle African American 
Glaucoma Genetics (POAAGG) study. 
DOI 10.1101/2020.02.27.968156
[24] Vranka JA, Kelley MJ, Acott TS, 
Keller KE. Extracellular matrix in the 
trabecular meshwork: intraocular 
pressure regulation and dysregulation in 
glaucoma. Experimental Eye Research. 
2015;133:112-25. DOI: 10.1016/j.
exer.2014.07.014.
[25] Ventura A, Bohnke M, Mojon D. 
Central corneal thickness measurements 
in patients with normal tension 
glaucoma, primary open angle 
glaucoma, pseudoexfoliation glaucoma, 
or ocular hypertension. British Journal 
of Ophthalmology. 2001;85:792-795.
[26] Medeiros FA, Weinreb RN. Is 
corneal thickness an independent risk 
factor for glaucoma? Ophthalmology. 
2012;119(3):435-6. DOI: 10.1016/j.
ophtha.2012.01.018.
[27] Miglior S, Zeyen T, Pfeiffer N, et 
al. European Glaucoma Prevention 
Study (EGPS) Group. Results of the 
European Glaucoma Prevention Study. 
Ophthalmology. 2005;112(3):366-75. 
DOI: 10.1016/j.ophtha.2004.11.030.
[28] Gordon M, Torri V, Miglior S, et 
al. Validated prediction model for 
the development of primary open-
angle glaucoma in individuals with 
ocular hypertension. Ophthalmology. 
2007;114(1):10-9. DOI: 10.1016/j.
ophtha.2006.08.031.
[29] Copt R, Thomas R, Memoud A.  
Corneal Thickness in Ocular 
Hypertension, Primary Open-angle 
Glaucoma, and Normal Tension 
11
Ocular Hypertension in Blacks
DOI: http://dx.doi.org/10.5772/intechopen.96606
Glaucoma. Archives of Ophthalmology. 
1999;117(1):14-16. DOI: 10.1001/
archopht.117.1.14
[30] Herman D, Hodge D, Bourne W. 
Increased Corneal Thickness in Patients 
With Ocular Hypertension. Archives of 
Ophthalmology. 2001;119(3):334-336. 
DOI:10.1001/archopht.119.3.334
[31] Baboolal SO, Smit DP. South 
African Eye Study (SAES): ethnic 
differences in central corneal thickness 
and intraocular pressure. Eye (Lond). 
2018;32(4):749-756. DOI: 10.1038/
eye.2017.291.
[32] Girkin CA. Differences in optic 
nerve structure between individuals of 
predominantly African and European 
ancestry: Implications for disease 
detection and pathogenesis. Clinical 
Ophthalmology. 2008;2(1):65-9. doi: 
10.2147/opth.s1628.
[33] Varma R, Tielsch JM,  
Quigley HA, Hilton SC, Katz J, 
Spaeth GL, Sommer A. Race-, age-, 
gender-, and refractive error-related 
differences in the normal optic 
disc. Archives of Ophthalmology. 
1994;112(8):1068-76. doi: 10.1001/
archopht.1994.01090200074026.
[34] Chi T, Ritch R, Stickler D, 
Pitman B, Tsai C, Hsieh FY. Racial 
differences in optic nerve head 
parameters. Archives of Ophthalmology. 
1989;107(6):836-9. DOI: 10.1001/
archopht.1989.01070010858029.
[35] Fortune B, Cull G, Reynaud J, 
Wang L, Burgoyne CF. Relating Retinal 
Ganglion Cell Function and Retinal 
Nerve Fiber Layer (RNFL) Retardance 
to Progressive Loss of RNFL Thickness 
and Optic Nerve Axons in Experimental 
Glaucoma. Investigative Ophthalmology 
& Visual Science. 2015;56(6):3936-44. 
doi: 10.1167/iovs.15-16548.
[36] Bowd C, Weinreb R, Williams J, 
et al. The Retinal Nerve Fiber Layer 
Thickness in Ocular Hypertensive, 
Normal, and Glaucomatous Eyes 
With Optical Coherence Tomography. 
Archives of Ophthalmology. 
2000;118(1):22-26. doi:10.1001/
archopht.118.1.22
[37] Zangwill L, van Horn S, De 
Souza M, et al. Optic Nerve Head 
Topography in Ocular Hypertensive 
Eyes Using Confocal Scanning Laser 
Ophthalmoscopy. American Journal of 
Ophthalmology. 1996;122(4):520-525.
[38] The International Agency for the 
Prevention of Blindness. Vision 2020 
[Internet] 2020. Available from: https://
www.iapb.org/about/vision-2020/ 
[Accessed 02-01-2021]
[39] Azuara-Blanco A, Burr J, 
Ramsay C, et al. Effectiveness of early 
lens extraction for the treatment 
of primary angle-closure glaucoma 
(EAGLE): a randomised controlled trial. 
Lancet. 2016;388(10052):1389-1397. 
DOI: 10.1016/S0140-6736(16)30956-4.
[40] Bazargan M, Ekwegh T, Cobb S, 
Adinkrah E, Assari S. Eye Examination 
Recency among African American 
Older Adults with Chronic Medical 
Conditions. Healthcare (Basel). 
2020;8(2):94. DOI: 10.3390/
healthcare8020094.
[41] The Century Foundation. Racism, 
Inequality, and Health Care for African 





[42] Brookings. Examining the Black-





[43] American Academy of 
Ophthalmology. Eye Health Statistics 
Ocular Hypertension
12
[Internet] 2021. Available from: https://
www.aao.org/newsroom/eye-health-
statistics [Accessed 02-01-2021]
[44] Sarrazin MS, Campbell ME, 
Richardson KK, Rosenthal GE. Racial 
segregation and disparities in health 
care delivery: conceptual model and 
empirical assessment. Health Services 
Research. 2009;44(4):1424-44. DOI: 
10.1111/j.1475-6773.2009.00977
[45] Scharff DP, Mathews KJ, Jackson P, 
Hoffsuemmer J, Martin E, Edwards D. 
More than Tuskegee: understanding 
mistrust about research participation. 
Journal of Health Care for the Poor and 
Underserved. 2010;21(3):879-97. DOI: 
10.1353/hpu.0.0323.
[46] Nuriddin A, Mooney G, White AIR. 
Reckoning with histories of medical 
racism and violence in the USA. Lancet. 
2020;396(10256):949-951. DOI: 10.1016/
S0140-6736(20)32032-8.
[47] American Bar Association. 
The Impact of Structural Racism 
in Employment and Wages on 
Minority Women’s Health [Internet] 






[48] The Federal Reserve System. 
Disparities in Wealth by Race and 
Ethnicity in the 2019 Survey of 
Consumer Finances [Internet] 






[49] Health Resources & Services 
Administration. MUA Find [Internet] 







[50] Ending systemic racism in medicine. 
Nature Medicine. 2020;26:985. DOI: 
10.1038/s41591-020-0993-2
[51] Kuczmarski AV, Cotugna N, 
Mason MA, Evans MK, Zonderman AB. 
Depression and Cognitive Impairment 
Are Associated with Low Education and 
Literacy Status and Smoking but Not 
Caffeine Consumption in Urban African 
Americans and White Adults. Journal of 
caffeine research. 2015;5(1):31-41. DOI: 
10.1089/jcr.2014.0019
[52] Tseng YC, Liu SH, Lou MF, 
Huang GS. Quality of life in older adults 
with sensory impairments: a systematic 
review. Quality of Life Research. 
2018;27(8):1957-1971. DOI: 10.1007/
s11136-018-1799-2.
[53] Swenor BK, Lee MJ, Varadaraj V, 
Whitson HE, Ramulu PY. Aging With 
Vision Loss: A Framework for Assessing 
the Impact of Visual Impairment 
on Older Adults. Gerontologist. 
2020;60(6):989-995. DOI: 10.1093/
geront/gnz117.
[54] Vu HT, Keeffe JE, McCarty CA, 
Taylor HR. Impact of unilateral and 
bilateral vision loss on quality of life. 
British Journal of Ophthalmology. 
2005;89(3):360-3. DOI: 10.1136/
bjo.2004.047498.
[55] National Academies of Sciences, 
Engineering, and Medicine. Health-
Care Utilization as a Proxy in Disability 




[56] Sommer A, Tielsch JM, 
Katz J, Quigley HA, Gottsch JD, Javitt JC, 
Martone JF, Royall RM, Witt KA, 
Ezrine S. Racial differences in the 
13
Ocular Hypertension in Blacks
DOI: http://dx.doi.org/10.5772/intechopen.96606
cause-specific prevalence of blindness 
in east Baltimore. New England Journal 
of Medicine. 1991;325(20):1412-7. DOI: 
10.1056/NEJM199111143252004.
[57] Johnson CA, Keltner JL, Cello KE, 
et al. Baseline visual field characteristics 
in the ocular hypertension 
treatment study. Ophthalmology. 
2002;109(3):432-7. DOI: 10.1016/
s0161-6420(01)00948-4
[58] Laroche D, Nkrumah G, Ng C. 
Real-world efficacy of the Hydrus 
microstent in Black and Afro-Latinx 
patients with glaucoma: a retrospective 
study. Therapeutic Advances in 
Ophthalmology 2020;12 1-9.
[59] Heijl A, Leske MC, Bengtsson B, et 
al. Reduction of intraocular pressure 
and glaucoma progression: results 
from the Early Manifest Glaucoma 
Trial. Archives of Ophthalmology. 
2002;120(10):1268-79. doi: 10.1001/
archopht.120.10.1268.
[60] Washington DL. Charting the 
path from lack of insurance to poor 
health outcomes. Western Journal of 
Medicine. 2001;175(1):23. DOI: 10.1136/
ewjm.175.1.23.
[61] Institute of Medicine (US) 
Committee on the Consequences of 
Uninsurance. Care Without Coverage: 
Too Little, Too Late. Effects of Health 




[62] Muñoz B, West SK, Rubin GS, 
et al. Causes of blindness and visual 
impairment in a population of 
older Americans: The Salisbury 
Eye Evaluation Study. Archives of 
Ophthalmology. 2000;118(6):819-25. 
DOI: 10.1001/archopht.118.6.819.
[63] HealthCare.Gov. Affordable Care 




[64] Sommers BD, McMurtry CL, 
Blendon RJ, et al. Beyond Health 
Insurance: Remaining Disparities in 
US Health Care in the Post-ACA Era. 
Milbank Quarterly. 2017;95(1):43-69. 
DOI: 10.1111/1468-0009.12245.
[65] Kaiser Family Foundation.
Changes in Health Coverage by 
Race and Ethnicity since the ACA, 






[66] Varadaraj V, Frick KD, Saaddine JB,  
et al. Trends in Eye Care Use and 
Eyeglasses Affordability: The US 
National Health Interview Survey, 
2008-2016. JAMA Ophthalmology. 
2019;137(4):391-398. DOI: 10.1001/
jamaophthalmol.2018.6799.
[67] Orr P, Barrón Y, Schein OD, 
et al. Eye care utilization by older 
Americans: the SEE Project. Salisbury 
Eye Evaluation. Ophthalmology. 
1999;106(5):904-9. DOI: 10.1016/
s0161-6420(99)00508-4.
[68] Greenidge KC, Dweck M. 
Glaucoma in the black population: 
a problem of blindness. Journal of 
the National Medical Association. 
1988;80(12):1305-9.
[69] Sleath B, Blalock SJ, Carpenter DM,  
et al. Provider Education about 
Glaucoma and Glaucoma Medications 
during Videotaped Medical 
Visits. Journal of Ophthalmology. 
2014;2014:238939. DOI: 
10.1155/2014/238939.
[70] Population Reference Bureau. 
America’s Aging Population [Internet] 





[71] Unzueta M, Globe D, Wu J, et al. 
Compliance with recommendations 
for follow-up care in Latinos: the Los 
Angeles Latino Eye Study. Ethnicity & 
Disease. 2004;14(2):285-91.
